Perx Health Raises USD$2.2M in Seed Funding

Perx Health

Perx Health, an Australian digital health startup, raised $3m in AUD ($2.2M USD) seed funding.

The round was led by AirTree Ventures.

The company intends to use the funds to expand into the U.S.

Launched in 2017 by Scott Taylor, CEO, Perx provides a behavior change platform that helps people with chronic health conditions like diabetes and complex behavioral health conditions adhere to daily treatment plans. Perx offers a single solution that works across any condition (or multiple conditions) managed by patients, including diabetes, cardiovascular, behavioral and mental health, respiratory, and musculoskeletal conditions, as well as less prevalent conditions like Hepatitis C and HIV. It has also been validated for patients with complex social determinants of health, such as vulnerable public hospital patients with multiple chronic conditions and a government-sponsored program for higher-risk Indigenous Australians living with COVID-19.

Perx Health partners with health plans, healthcare systems, and employers to build high-engagement programs that deliver meaningful, sustainable behavior change for chronic conditions. It is already used by major global healthcare brands such as AIA, QBE, Roche and AstraZeneca, and Australia’s national healthcare system.

Coupled with the market expansion and capital raise, Taylor has relocated to lead Perx’s new U.S. team, which includes Sales and Marketing professionals from leading U.S. digital health companies like Omada, Physera, Propeller, Diagnostic Robotics, and Crossover Health. The company is also introducing its advisory board that includes senior executives Fawad Butt, former Chief Data Officer of UnitedHealthcare, and Dr. Mike Cantor, former Chief Medical Officer of Bright Health.

The U.S. headquarters is in Chicago, Illinois.